Search Symbol

Most Active Stocks

NIACL

HDFCBANK

DMART

VBL

TATAMOTORS

ICICIBANK

JAYNECOIND

RELIANCE

BHARTIARTL

EBGNG

AXISBANK

TCS

INFY

WAAREEENER

AMBER

KOTAKBANK

M&M

SBIN

INDIGO

Lupin Limited

Drug Manufacturers - Specialty & Generic | Healthcare

Company Overview

Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India and internationally. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutical ingredients (APIs). The company offers formulations for use in the therapeutic areas of anti-tuberculosis, diabetes management, cardiovascular, chronic obstructive pulmonary diseases, asthma, gynecology and women's health, central nervous system, oncology, immunology, genomics, metabolic disorders, dermatology, urology, pediatrics, gastrointestinal, anti-infective, and nonsteroidal anti-inflammatory drug therapies, as well as engages in the bio clinical research activities. It operates through network consists of labs, LupiMitra collection centers, and pick-up points. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.

Key Information

Market Cap

894741839872

Current Price

1903.2

52 Week Range

1774.05 - 2402.9

Previous Close

1921.0

Open

1930.0

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Contact Details

Address

Kalpataru Inspire, 3rd Floor Off. Western Expressway Highway Santacruz (East), Mumbai, 400055, India

Phone

+91-22664-02323

Fax

+91-22664-02051

Website

https://www.lupin.com

Financials

Day Low

1877.3

Day High

1947.5

Dividend Yield

0.62

PE Ratio

26.562454

Earnings Per Share

71.65

Beta

0.29

EBITDA

50912698368

Book Value

376.803

EPS

88.07086

Company Officers

Name	Title	Age	Year Born
Ms. Vinita D. Gupta	CEO & Executive Director	56	1968
Mr. Ramesh Swaminathan	Executive Director, Global CFO, CRO & Head of API, Sustainability and IT	58	1966
Mr. Nilesh Deshbandhu Gupta	MD & Executive Director	50	1974
Mr. Christoph Funke	Chief Technical Operations Officer	-	-
Mr. Sreeji Gopinathan	Chief Information Officer	-	-
Dr. Shahin Fesharaki	President -Global Chief Scientific Officer	-	-
Mr. Ravi Agrawal	Sr. Vice President of Investor Relations and M&A	-	-
Dr. Sofia Mumtaz	President of Legal and Compliance of Australia, Japan & Canada Business	-	-
Mr. Amit Kumar Gupta	Company Secretary & Compliance Officer	-	-
Ms. Rajalakshmi Azariah	Vice President & Global Head of Corporate Communications	-	-